In a disappointing setback, a promising experimental AIDS vaccine failed to work in a large international test, leading the developer to halt the study.
Merck & Co said on Friday that it is ending enrollment and vaccination of volunteers in the study, which was partly funded by the National Institutes of Health (NIH).
It was a high-profile failure in the daunting quest to develop a vaccine to prevent AIDS. Merck's vaccine was the farthest along, considered the most promising and was closely watched by experts in the field.
Officials at the company, based in Whitehouse Station, New Jersey, said 24 of 741 volunteers who got the vaccine in one segment of the experiment later became infected with HIV, the virus that causes AIDS.
In a comparison group of volunteers who got dummy shots, 21 of 762 participants also became infected.
"It's very disappointing news," said Keith Gottesdiener, head of Merck's clinical infectious disease and vaccine research group.
Michael Zwick, an HIV researcher at Scripps Research Institute, said it is too soon to know if other vaccines using the same strategy would also fail.
"It's par for the course in the HIV field," he said of the Merck result.
The volunteers in the experiment were all free of HIV at the start. But they were at high risk for getting the virus: Most were homosexual men or female sex workers. They were all repeatedly counseled about how to reduce their risk of HIV infections, including use of condoms, according to Merck.
In a statement, the NIH said a data safety monitoring board, reviewing interim results, found the vaccine did not prevent HIV infection. Nor did it limit severity of the disease "in those who become infected with HIV as a result of their own behaviors that exposed them to the virus" -- another goal of the study.
Merck's was the first major test of a new strategy to prevent HIV infection.
The first wave of attempts to develop a vaccine tried to stimulate antibodies against the virus, but that hasn't worked so far.
The new effort -- an approach that Gottesdiener said is being tried in most other current research -- is aimed at making the body produce more of a crucial immune cell called killer T cells. The goal is to simultaneously "train" those cells, like an army, to quickly recognize and destroy the AIDS virus when it enters cells in the bloodstream.
Anthony Fauci, head of NIH's National Institute of Allergy and Infectious Diseases, said other vaccines are in line for testing that use a similar strategy but with important differences.
One developed by the NIH -- containing the same three genes as the Merck vaccine, plus three versions of another gene -- is set in January to enter the same large, "proof of concept" testing stage as the Merck vaccine, Fauci said.
Zwick said some researchers still are working on vaccines to neutralize the AIDS virus. He thinks ultimately what is needed is one that combines that approach with a way to stimulate and train killer T cells.
Merck and the HIV Vaccine Trials Network, an international collaboration of researchers and institutions funded by the NIH, cosponsored the study. The experiment, called STEP, began in December 2004 and had enrolled 3,000 volunteers in Australia, Brazil, Canada, the Dominican Republic, Haiti, Jamaica, Peru, Puerto Rico and the US.
Mark Feinberg, head of medical affairs in Merck's vaccine division, said it has no other candidates in development.
The company still must do a detailed review of the data but he said he thinks this approach is dead.
Other scientists disagreed.
"You can't say that the whole field of T cell vaccines has been dealt a death blow" by the Merck results, Fauci said.
Eleven people, including a former minister, were arrested in Serbia on Friday over a train station disaster in which 16 people died. The concrete canopy of the newly renovated station in the northern city of Novi Sad collapsed on Nov. 1, 2024 in a disaster widely blamed on corruption and poor oversight. It sparked a wave of student-led protests and led to the resignation of then-Serbian prime minister Milos Vucevic and the fall of his government. The public prosecutor’s office in Novi Sad opened an investigation into the accident and deaths. In February, the public prosecutor’s office for organized crime opened another probe into
RISING RACISM: A Japanese group called on China to assure safety in the country, while the Chinese embassy in Tokyo urged action against a ‘surge in xenophobia’ A Japanese woman living in China was attacked and injured by a man in a subway station in Suzhou, China, Japanese media said, hours after two Chinese men were seriously injured in violence in Tokyo. The attacks on Thursday raised concern about xenophobic sentiment in China and Japan that have been blamed for assaults in both countries. It was the third attack involving Japanese living in China since last year. In the two previous cases in China, Chinese authorities have insisted they were isolated incidents. Japanese broadcaster NHK did not identify the woman injured in Suzhou by name, but, citing the Japanese
YELLOW SHIRTS: Many protesters were associated with pro-royalist groups that had previously supported the ouster of Paetongtarn’s father, Thaksin, in 2006 Protesters rallied on Saturday in the Thai capital to demand the resignation of court-suspended Thai Prime Minister Paetongtarn Shinawatra and in support of the armed forces following a violent border dispute with Cambodia that killed more than three dozen people and displaced more than 260,000. Gathered at Bangkok’s Victory Monument despite soaring temperatures, many sang patriotic songs and listened to speeches denouncing Paetongtarn and her father, former Thai prime minister Thaksin Shinawatra, and voiced their backing of the country’s army, which has always retained substantial power in the Southeast Asian country. Police said there were about 2,000 protesters by mid-afternoon, although
MOGAMI-CLASS FRIGATES: The deal is a ‘big step toward elevating national security cooperation with Australia, which is our special strategic partner,’ a Japanese official said Australia is to upgrade its navy with 11 Mogami-class frigates built by Japan’s Mitsubishi Heavy Industries, Australian Minister for Defence Richard Marles said yesterday. Billed as Japan’s biggest defense export deal since World War II, Australia is to pay US$6 billion over the next 10 years to acquire the fleet of stealth frigates. Australia is in the midst of a major military restructure, bolstering its navy with long-range firepower in an effort to deter China. It is striving to expand its fleet of major warships from 11 to 26 over the next decade. “This is clearly the biggest defense-industry agreement that has ever
RSS